Neuro-Urology pp 105-117 | Cite as

Clinical Entities and Their Neuro-urological Consequences: Infections

  • Mikolaj Przydacz
  • Jacques CorcosEmail author


Infections of the nervous system can significantly affect bladder function as a result of peripheral and/or central neuropathy. Due to a wide variety of possible pathogens, clinical presentation varies. Both urological and non-urological symptoms may appear. Retention is the most common urological dysfunction, followed by urinary incontinence with frequency and urgency. Treatment should be implemented as soon as reasonably possible and tailored to underlying pathology.


Neurogenic bladder Infection Neuropathy 


  1. 1.
    Tse V, Stone A. Other peripheral neuropathies (lumbosacral herpes zoster, genitourinary herpes, tabes dorsalis, Guillain–Barré syndrome). In: Corcos J, Ginsberg D, Karsenty G, editors. Textbook of the neurogenic bladder. 3rd ed. Boca Raton: CRC Press; 2016. p. 260–4.Google Scholar
  2. 2.
    Gibbon N. A case of herpes zoster with involvement of urinary bladder. Br J Urol. 1956;28:417–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Rankin JT, Sutton RA. Herpes zoster causing retention of urine. Br J Urol. 1969;41:238–41.CrossRefPubMedGoogle Scholar
  4. 4.
    Kendall AR, Karafin L. Classification of neurogenic bladder disease. Urol Clin N Am. 1974;1:45.Google Scholar
  5. 5.
    Bastian FO, Rabson AS, Yee CL, Tralka TS. Herpesvirus varicellae: isolated from human dorsal root ganglia. Arch Pathol. 1974;97:331–3.PubMedGoogle Scholar
  6. 6.
    Yamanishi T, Yasuda K, Sakakibara R, et al. Urinary retention due to herpes virus infections. Neurourol Urodyn. 1998;17:613–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Worrell JT, Cockerell CJ. Histopathology of peripheral nerves in cutaneous herpes virus infection. Am J Dermatopathol. 1997;19:133–7.CrossRefPubMedGoogle Scholar
  8. 8.
    van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–82.CrossRefPubMedGoogle Scholar
  9. 9.
    Pascuzzi R, Fleck J. Acute peripheral neuropathy in adults. Neurol Clin. 1997;15(3):529–48.CrossRefPubMedGoogle Scholar
  10. 10.
    Honavar M, Tharakan JKJ, Hughes RAC, et al. A clinicopathological study of the Guillain–Barré syndrome; nine cases and literature review. Brain. 1991;114:1245–69.CrossRefPubMedGoogle Scholar
  11. 11.
    Hanus T. Other diseases (transverse myelitis, tropical spastic paraparesis, progressive multifocal leukoencephalopathy, Lyme’s disease). In: Corcos J, Ginsberg D, Karsenty G, editors. Textbook of the neurogenic bladder. 3rd ed. Boca Raton: CRC Press; 2016. p. 260–4.Google Scholar
  12. 12.
    Bratt G, Hammarin AL, Grandien M, et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS. 1999;13(9):1071–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Gessaia A, Barin F, Vemant JC, et al. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet B. 1985;407–9(16):5.Google Scholar
  14. 14.
    Cruickshank JK, Rudge P, Dalgkish AG, et al. Tropical spastic paraparesis and human T cell lymphotropic virus type l in the United Kingdom. Brain. 1989;112:1057–90.CrossRefPubMedGoogle Scholar
  15. 15.
    Iwasaki Y. Pathology of chronic myelopathy associated with HTLV1 infection (HAM/TSP). Neurol Sci. 1990;6:103–23.CrossRefGoogle Scholar
  16. 16.
    Carod-Artal FJ, Del-Negro MC, Vargas AP, Rizzo I. Cerebellar syndrome and peripheral neuropathy as manifestations of infection by HTLV-I human T-cell lymphotropic virus. Rev Neurol. 1999;29(9):932–5.PubMedGoogle Scholar
  17. 17.
    Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, et al. Expert review on poliovirus immunity and transmission. Risk Anal. 2013;33(4):544–605.CrossRefPubMedGoogle Scholar
  18. 18.
    Gyrtrup HJ, Kristiansen VB, Zachariae CO, Krogsgaard K, Colstrup H, Jensen KM. Voiding problems in patients with HIV infection and AIDS. Scand J Urol Nephrol. 1995;29:295–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Staiman VR, Lowe FC. Urologic problems in patients with acquired immunodeficiency syndrome. ScientificWorldJournal. 2004;4(Suppl 1):427–37.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Broseta E, Osca JM, Morera J, et al. Urological manifestations of herpes zoster. Eur Urol. 1993;24:244–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Chen PH, Hsueh HF, Hong CZ. Herpes zoster-associated voiding dysfunction: a retrospective study and literature review. Arch Phys Med Rehabil. 2002;83(11):1624–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Greenstein A, Matzkin H, Kaver I, Braf Z. Acute urinary retention in herpes genitalis infection. Urology. 1988;31(5):453–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Sakakibara R, Hattori T, Kuwabara S, et al. Micturitional disturbance in patients with Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry. 1997;63:649–53.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Murphy EL, Fridey J, Smith JW, et al. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. Neurology. 1997;48:315–20.CrossRefPubMedGoogle Scholar
  25. 25.
    Howard RS, Wiles CM, Spencer GT. The late sequelae of poliomyelitis. Q J Med. 1988;66:219–32.PubMedGoogle Scholar
  26. 26.
    Johnson VY, Hubbard D, Vordermark JS. Urologic manifestations of post-polio syndrome. J Wound Ostomy Continence Nurs. 1996;23:218–23.PubMedGoogle Scholar
  27. 27.
    Krishnan C, Kaplin AI, Pardo CA, Kerr DA, Keswani SC. Demyelinating disorders: update on transverse myelitis. Curr Neurol Neurosci Rep. 2006;6(3):236–43.CrossRefPubMedGoogle Scholar
  28. 28.
    Oliveira P, Castro NM, Muniz AL, et al. Prevalence of erectile dysfunction in HTLV-1–infected patients and its association with overactive bladder. Urology. 2010;75:1100–3.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Christova I, Komitova R. Clinical and epidemiological features of Lyme borreliosis in Bulgaria. Wien Klin Wochenschr. 2004;116(1–2):42–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Nygarg K, Bransaeter AB, Mehl A. Disseminated and chronic Lyme borreliosis in Norway, 1995–2004. Euro Surveill. 2005;10(10):83–5.Google Scholar
  31. 31.
    Aksamit AJ. Review of PML and natalizumab. Neurologist. 2006;12(6):293–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Kobylecki C, Lee L, Kellett M. Cerebral palsy, cerebellar ataxia, AIDS, phacomatosis, neuromuscular disorders, and epilepsy. In: Corcos J, Ginsberg D, Karsenty G, editors. Textbook of the neurogenic bladder. 3rd ed. Boca Raton: CRC Press; 2016. p. 260–4.Google Scholar
  33. 33.
    Cohen LM, Fowler JF, Owen LG, Callen JP. Urinary retention associated with herpes zoster infection. Int J Dermatol. 1993;32(1):24–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Clason AE, McGeorge A, Garland C, Abel BJ. Urinary retention and granulomatous prostatitis following sacral herpes zoster infection. Br J Urol. 1982;54:166–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Riehle RA Jr, Williams JJ. Transient neuropathic bladder following herpes simplex genitalis. J Urol. 1979;122(2):263–4.CrossRefPubMedGoogle Scholar
  36. 36.
    Wheeler JS Jr, Culkin DJ, O’Hara RJ, Canning JR. Bladder dysfunction and neurosyphilis. J Urol. 1986;136:903–5.CrossRefPubMedGoogle Scholar
  37. 37.
    Kogan BA, Soloman MH, Diokno AC. Urinary retention secondary to Landry–Guillain–Barré syndrome. J Urol. 1981;126:643–4.CrossRefPubMedGoogle Scholar
  38. 38.
    Grbavac Z, Gilja I, Gubarev N, Bozicevic D. Neurologic and urodynamic characteristics of patients with Guillain–Barré syndrome. Lijec Vjesn. 1989;111(1–2):17–20.PubMedGoogle Scholar
  39. 39.
    Timmermans L, Bonnet F, Maquinay C. Urological complications of poliomyelitis and their treatment. Acta Urol Belg. 1965;33:409–26.PubMedGoogle Scholar
  40. 40.
    Menendez V, Valls J, Espuna M, Perez A, Barranco MA, Carretero P. Neurogenic bladder in patients with acquired immunodeficiency syndrome. Neurourol Urodyn. 1995;14:253–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Hermieu JF, Delmas V, Boccon-Gibod L. Micturition disturbances and human immunodeficiency virus infection. J Urol. 1996;156:157–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Zeman A, Donaghy M. Acute infection with human immunodeficiency virus presenting with neurogenic urinary retention. Genitourin Med. 1991;67:345–7.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Kalita J, Shah S, Kapoor R, Misra UK. Bladder dysfunction in acute transverse myelitis: magnetic resonance imaging and neurophysiological and urodynamic correlations. J Neurol Neurosurg Psychiatry. 2002;73(2):154–9.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Leroy-Malherbe V, Sebire G, Hollenberg H, Tardieu M, Landrieu P. Neurogenic bladder in children with acute transverse myelopathy. Arch Pediatr. 1998;5(5):497–502.CrossRefPubMedGoogle Scholar
  45. 45.
    Chancellor MB, Dato VM, Yang JY. Lyme disease presenting as urinary retention. J Urol. 1990;143(6):1223–4.CrossRefPubMedGoogle Scholar
  46. 46.
    Troisgros O, Barnay JL, Darbon-Naghibzadeh F, Olive P, René-Corail P. Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Neurourol Urodyn. 2016;36(2):449–52.CrossRefPubMedGoogle Scholar
  47. 47.
    Sakiyama H, Nishi K, Kikukawa H, Ueda S. Urinary disturbance due to HTLV-1 associated myelopathy. Nippon Hinyokika Gakkai Zasshi. 1992;83(12):2058.PubMedGoogle Scholar
  48. 48.
    Yamashita H, Kumazawa J. Voiding dysfunction: patients with human T-lymphotropic-virus-type-1-associated myelopathy. Urol Int. 1991;47(Suppl 1):69–71.CrossRefPubMedGoogle Scholar
  49. 49.
    Imamura A. Studies on neurogenic bladder due to human T-lymphotropic virus type-I associated myelopathy (HAM). Nippon Hinyokika Gakkai Zasshi. 1994;85(7):1106–15.PubMedGoogle Scholar
  50. 50.
    Nomata K, Nakamura T, Suzu H, et al. Novel complications with HTLV-1-associated myelopathy/tropical spastic paraparesis: interstitial cystitis and persistent prostatitis. Jpn J Cancer Res. 1992;83(6):601–8.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Ganesan V, Borzyskowski M. Characteristics and course of urinary tract dysfunction after acute transverse myelitis in childhood. Dev Med Child Neurol. 2001;43(7):473–5.CrossRefPubMedGoogle Scholar
  52. 52.
    Sakakibara R, Hattori T, Yasuda K, Yamanishi T. Micturition disturbance in acute transverse myelitis. Spinal Cord. 1996;34(8):481–5.CrossRefPubMedGoogle Scholar
  53. 53.
    Berger Y, Blaivas JG, Oliver L. Urinary dysfunction in transverse myelitis. J Urol. 1990;144(1):103–5.CrossRefPubMedGoogle Scholar
  54. 54.
    Chancellor MB, McGinnis DE, Shenot PJ, Kiilholma P, Hirsch IH. Urinary dysfunction in Lyme disease. J Urol. 1993;149(1):26–30.CrossRefPubMedGoogle Scholar
  55. 55.
    Chancellor MB, McGinnis DE, Shenot PJ, Hirsch IH, Kiilholma PJ. Lyme cystitis and neurogenic bladder dysfunction. Lancet. 1992;339(8803):1237–8.CrossRefPubMedGoogle Scholar
  56. 56.
    Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59:499–505.CrossRefGoogle Scholar
  57. 57.
    Roskopf J, Trofe J, Stratta RJ, Ahsan N. Pharmacotherapeutic options for the management of human polyomaviruses. Adv Exp Med Biol. 2006;577:228–54.CrossRefPubMedGoogle Scholar
  58. 58.
    Andrade RC, Neto JA, Andrade L, et al. Effects of physiotherapy in the treatment of neurogenic bladder in patients infected with human T-Lymphotropic virus 1. Urology. 2016;89:33–8.CrossRefPubMedGoogle Scholar
  59. 59.
    Tsiodras S, Kelesidis T, Kelesidis I, Voumbourakis K, Giamarellou H. Mycoplasma pneumoniae-associated myelitis: a comprehensive review. Eur J Neurol. 2006;13(2):112–24.CrossRefPubMedGoogle Scholar
  60. 60.
    Olivares JP, Pallas F, Ceccaldi M, et al. Lyme disease presenting as isolated acute urinary retention caused by transverse myelitis: an electrophysiological and urodynamical study. Arch Phys Med Rehabil. 1995;76(12):1171–2.CrossRefPubMedGoogle Scholar
  61. 61.
    Chartier-Kastler EJ, Rudd Bosch JL, Perrigot M, et al. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol. 2000;164(5):1476–80.CrossRefPubMedGoogle Scholar
  62. 62.
    Wosnitzer MS, Walsh R, Rutman MP. The use of sacral neuromodulation for the treatment of non-obstructive urinary retention secondary to Guillain-Barré syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(9):1145–7.CrossRefPubMedGoogle Scholar
  63. 63.
    Hattori T, Yasuda K, Kita K, Hirayama K. Disorders of micturition in tabes dorsalis. Br J Urol. 1990;65(5):497–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Mcgill UniversityMontrealCanada

Personalised recommendations